TY - JOUR T1 - FDA’s Biomedical Research Program JF - PDA Journal of Pharmaceutical Science and Technology JO - PDA J Pharm Sci Technol SP - 134 LP - 138 VL - 34 IS - 2 AU - Frances O. Kelsey Y1 - 1980/03/01 UR - http://journal.pda.org/content/34/2/134.abstract N2 - The agency-wide Bioresearch Monitoring Program was initiated in 1977. Its goals are to ensure the integrity of preclinical and clinical data submitted in support of applications for approval of agency-regulated products and to assure that subjects of clinical tests are not exposed to unnecessary risks. An update of the educational and regulatory actirities under this program will be presented and pertinent findings of surveillance and compliance inspections of non-clinical laboratories, sponsors and monitors. and institutional reicew boards will be described and discussed. ER -